BioVie, Inc. (BIVI)
2.08
-0.06
(-2.80%)
USD |
NASDAQ |
Aug 25, 16:00
2.055
-0.02
(-1.20%)
After-Hours: 17:27
BioVie Price : 2.08 for Aug. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 1.812 | 2.145 | 1.76 | 2.14 | 2.174M |
| Aug 21, 2026 | 2.155 | 2.48 | 1.80 | 1.95 | 19.76M |
| Aug 20, 2026 | 1.545 | 2.39 | 1.490 | 1.86 | 49.11M |
| Aug 19, 2026 | 1.30 | 1.44 | 1.14 | 1.34 | 42.47M |
| Aug 18, 2026 | 1.13 | 1.14 | 0.945 | 0.9644 | 10.54M |
| Aug 17, 2026 | 1.32 | 1.56 | 1.17 | 1.17 | 2.765M |
| Aug 14, 2026 | 1.415 | 1.515 | 1.245 | 1.40 | 2.119M |
| Aug 13, 2026 | 1.65 | 1.70 | 1.48 | 1.56 | 4.878M |
| Aug 12, 2026 | 1.35 | 3.79 | 1.31 | 1.56 | 126.40M |
| Aug 11, 2026 | 1.09 | 1.415 | 1.09 | 1.27 | 2.714M |
| Aug 10, 2026 | 0.9896 | 1.155 | 0.9852 | 1.10 | 1.249M |
| Aug 07, 2026 | 1.22 | 1.23 | 0.98 | 0.9993 | 3.456M |
| Aug 06, 2026 | 1.36 | 1.41 | 0.82 | 1.35 | 8.781M |
| Aug 05, 2026 | 1.89 | 2.09 | 1.87 | 2.04 | 247942.0 |
| Aug 04, 2026 | 1.63 | 1.90 | 1.535 | 1.83 | 397682.0 |
| Aug 03, 2026 | 1.50 | 1.65 | 1.46 | 1.62 | 119437.0 |
| Jul 31, 2026 | 1.45 | 1.55 | 1.38 | 1.52 | 203811.0 |
| Jul 30, 2026 | 1.30 | 1.45 | 1.30 | 1.43 | 225462.0 |
| Jul 29, 2026 | 1.34 | 1.399 | 1.26 | 1.26 | 81590.00 |
| Jul 28, 2026 | 1.36 | 1.401 | 1.31 | 1.33 | 106213.0 |
| Jul 27, 2026 | 1.36 | 1.43 | 1.35 | 1.37 | 75562.00 |
| Jul 24, 2026 | 1.45 | 1.49 | 1.34 | 1.37 | 112044.0 |
| Jul 23, 2026 | 1.34 | 1.46 | 1.34 | 1.44 | 85472.00 |
| Jul 22, 2026 | 1.28 | 1.38 | 1.28 | 1.34 | 105456.0 |
| Jul 21, 2026 | 1.41 | 1.456 | 1.26 | 1.29 | 306233.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 8.34 |
| Amgen, Inc. | 442.54 |
| Anika Therapeutics, Inc. | 21.52 |
| BioCryst Pharmaceuticals, Inc. | 9.845 |
| Imunon, Inc. | 1.62 |
Price Related Metrics
| Price to Book Value | 1.528 |
| Earnings Yield | -153.7% |
| Market Cap | 15.69M |